James Aikins - Concepedia

Author

James Aikins

Eli Lilly (United States)

Also Known As

Aikins J, Aikins, J.A., Eugenia Girda, J Aikins, J. A. AIKINS, J. AIKINS, J. Aikins, James A. Aikins, James Aikins

Publications

785

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

James Aikins is an author at Eli Lilly (United States) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	422
2	Natural Sciences	8	8	357
3	Biochemistry	8	8	352
4	Engineering	4	4	199
5	Applied Physics	1	1	10

James Aikins

Publications

726

Citations

H-Index

Page 1

	Year	Citations
Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships J. Jeffry Howbert, C. S. Grossman, Thomas A. Crowell, Journal of Medicinal Chemistry	1990	135
The First Total Synthesis of Lipid II: The Final Monomeric Intermediate in Bacterial Cell Wall Biosynthesis Michael S. VanNieuwenhze, Scott C. Mauldin, Mohammad Zia‐Ebrahimi, Journal of the American Chemical Society Bioorganic ChemistryLipid IiEngineeringPeptide EngineeringGlycobiology	2002	117
Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors Jian Liang, Richard E. Moore, Eric D. Moher, Investigational New Drugs Human TumorsTumor BiologyChemoprevention StrategyMedicineOther Cryptophycin Analogs	2005	74
Phase II Study of Mifepristone (RU486) in Refractory Ovarian Cancer Thomas F. Rocereto, Howard M. Saul, James Aikins, Gynecologic Oncology Refractory Ovarian CancerMedicineGynecologyOvarian HormoneOncology	2000	74
Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents Karen L. Lobb, Philip A. Hipskind, James Aikins, Journal of Medicinal Chemistry Organic ChemistryChemistryHuman Tumor XenograftsRelated Diaryl AcylsulfonamidesPharmaceutical Chemistry	2004	67
The Total Synthesis of Lipid I Michael S. VanNieuwenhze, Scott C. Mauldin, Mohammad Zia‐Ebrahimi, Journal of the American Chemical Society Lipid PreparationBiosynthesisEngineeringBiochemistryLipid Metabolism	2001	50
The First Total Synthesis of Bacterial Cell Wall Precursor UDP−<i>N</i>-Acetylmuramyl-Pentapeptide (Park Nucleotide) Stephen A. Hitchcock, Clark N. Eid, James Aikins, Journal of the American Chemical Society BacteriologyFirst Total SynthesisMolecular BiologyAltmetric Attention ScorePark Nucleotide	1998	48
Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors Timothy A. Shepherd, James Aikins, David Bleakman, Journal of Medicinal Chemistry Combinatorial ChemistryPotent PotentiatorsOrganic ChemistryPharmacotherapyChemistry	2002	36
Enantioselective Syntheses of 1-Carbacephalosporins from Chemoenzymically Derived β-Hydroxy-α-Amino Acids: Applications to the Total Synthesis of Carbacephem Antibiotic Loracarbef Billy Grinnell Jackson, Steve W Pedersen, Jack W. Fisher, Tetrahedron Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesCarbacephem Antibiotic Loracarbef	2000	28
Synthesis of a Peroxime Proliferator Activated Receptor (PPAR) α/γ Agonist via Stereocontrolled Williamson Ether Synthesis and Stereospecific S<sub>N</sub>2 Reaction of <i>S</i>-2-Chloro Propionic Acid with Phenoxides James Aikins, Michael Haurez, John‐Ross Rizzo, The Journal of Organic Chemistry Bioorganic ChemistryPhenol 4Organic ChemistryChemistryPharmaceutical Chemistry	2005	28

Page 1